Tersera Therapeutics LLC
Records under this name other than the patents Tersera Therapeutics LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 28 patents it holds.
Back to Tersera Therapeutics LLC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,697,071 | Identification and Engineering of Antibodies with Variant FC Regions and Methods of Using Same Term ended Term ended Aug 10, 2026 · Medium confidence | Term ended | Term ended Aug 10, 2026 | Medium confidence |
| US 8,192,737 | Identification and Engineering of Antibodies with Variant FC Regions and Methods of Using Same Term ended Ended no later than Sep 1, 2025 · Medium confidence | Term ended | Ended no later than Sep 1, 2025 | Medium confidence |
| US 7,355,008 | Identification and Engineering of Antibodies with Variant FC Regions and Methods of Using Same Term ended Ended no later than Jan 13, 2025 · Medium confidence | Term ended | Ended no later than Jan 13, 2025 | Medium confidence |
| US 8,003,774 | Identification and Engineering of Antibodies with Variant FC Regions and Methods of Using Same Term ended Term ended Jan 13, 2025 · Medium confidence | Term ended | Term ended Jan 13, 2025 | Medium confidence |
| US 9,707,270 | Method for Administering Omega-Conopeptide Term ended Ended no later than Dec 7, 2024 · Low confidence | Term ended | Ended no later than Dec 7, 2024 | Low confidence |
| US 7,268,109 | Method for Reducing Pain Term ended Term ended Oct 1, 2024 · High confidence | Term ended | Term ended Oct 1, 2024 | High confidence |
| US 7,524,812 | Pharmaceutical Formulation Comprising Ziconotide Term ended Term ended Oct 1, 2024 · High confidence | Term ended | Term ended Oct 1, 2024 | High confidence |
| US 7,833,973 | Pharmaceutical Formulations for Reducing Pain Term ended Term ended Oct 1, 2024 · Medium confidence | Term ended | Term ended Oct 1, 2024 | Medium confidence |
| US 7,956,030 | Method for Reducing Pain with Ziconotide and Baclofen Term ended Term ended Oct 1, 2024 · Medium confidence | Term ended | Term ended Oct 1, 2024 | Medium confidence |
| US 7,977,307 | Method for Reducing Pain with Ziconotide and Morphine Term ended Term ended Oct 1, 2024 · Medium confidence | Term ended | Term ended Oct 1, 2024 | Medium confidence |